Journal of Clinical Pathology · 1997 · 40 citations · 19 references
MedicineCell BiologyPathologyBone MetabolismCellular PathologyInflammationBone PathologyBone TissueJoint DiseaseJoint PathologyOsteoclast BiologySynovial InflammationCalcitonin Receptor ExpressionCalcitonin Receptor SignalingGiant Cell LesionsInflammatory Synovial PathologyMultinucleated Giant CellsOsteoclast-mediated Bone DestructionSynovial MassesTartrate-resistant Acid Phosphatase Activity
AIM: To determine the cytochemical and functional phenotype of multinucleated giant cells in pigmented villo nodular synovitis (PVNS). METHODS: Giant cells isolated from a patient with PVNS of the knee were assessed for a number of markers used to distinguish osteoclasts from macrophages/ macrophage polykaryons: evidence of tartrate resistant acid phosphatase (TRAP) activity; expression of CD11b, CD14, CD51, and calcitonin receptors; and the ability of the giant cells to carry out lacunar resorption. RESULTS: Isolated giant cells expressed an osteoclast antigenic phenotype (positive for CD51, negative for CD11b and CD14) and were TRAP and calcitonin receptor positive. They also showed functional evidence of osteoclast differentiation, producing numerous lacunar bone resorption pits on bone slices in short term culture. CONCLUSIONS: The giant cells in this case of PVNS express all the phenotypical features of osteoclasts including the ability to carry out lacunar resorption. This may account for the bone destruction associated with this aggressive synovial lesion.
19
Pigmented villonodular synovitis, bursitis and tenosynovitis
Hl Jaffe · Medical Entomology and Zoology · 1941 · 678 citations
The human osteoclast precursor circulates in the monocyte fraction.
Y. Fujikawa, J Quinn, A Sabokbar et al. · Endocrinology · 1996 · 345 citations · Full text
Medicine, Cell Biology, Immunology +16
Pigmented villonodular synovitis.
Fred Flandry, Jack C. Hughston · Journal of Bone and Joint Surgery · 1987 · 291 citations
Medicine, Cell Biology, Pathology +17